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Chemotactic Peptides*
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Andrew R. Dentino:j:, Periathamby Antony Raj, Krishna K. Bhandary, Mark E. Wilson, and
Michael J. Levine
From the Department of Oral Biology and Dental Research Institute, State University of New York, Buffalo, New York 14214

To investigate the role of peptide backbone conformation on the biological activity of chemotactic peptides, we synthesized a unique analog of N-formylMet-Leu-Phe-OH incorporating the ca,a disubstituted
residue, dipropylglycine (Dpg) in place of Leu. The
conformation of the stereochemically constrained Dpg
analog was examined in the crystalline state by x-ray
diffraction and in solution using NMR, IR, and CD
methods. The secretagogue activity of the peptide on
human neutrophils was determined and compared with
that of a stereochemically constrained, folded type II
/j-turn analog incorporating 1-aminocyclohexanecarboxylic acid (Acsc) at position 2 (f-Met-Acsc-PheOMe), the parent peptide (f-Met-Leu-Phe-OH) and its
methyl ester derivative (f-Met-Leu-Phe-OMe). In the
solid state, the Dpg analog adopts an extended /j-sheetlike structure with an intramolecular hydrogen bond
between the NH and CO groups of the Dpg residue,
thereby forming a fully extended (C5) conformation at
position 2. The q, and y; values for Met and Phe residues
are significantly lower than the values expected for an
ideal antiparallel {3 conformation causing a twist in the
extended backbone both at the N and C termini. Nuclear magnetic resonance studies suggest the presence
of a significant population of the peptide molecules in
an extended antiparallel {3 conformation and the involvement of Dpg NH in a C5 intramolecular hydrogen
bond in solutions of deuterated chloroform and deuterated dimethyl sulfoxide. IR studies provide evidence
for the presence of an intramolecular hydrogen bond
in the molecule and the antiparallel extended conformation in chloroform solution. CD spectra in methanol,
trifluoroethanol, and trimethyl phosphate indicate that
the Dpg peptide shows slight conformational flexibility, whereas the folded Acsc analog is quite rigid. The
extended Dpg peptide consistently shows the highest
activity in human peripheral blood neutrophils, being
-8 and 16 times more active than the parent peptide
and the folded Ac 6 c analog, respectively. However, the
finding that all four peptides have ED 5 o (the molar
concentration of peptide to induce half-maximal enzyme release) values in the 10- 8 -10-9 M range suggests
that an induced fit mechanism may indeed be important
in this ligand-receptor interaction. Moreover, it is also
possible that alterations in the backbone conformation
at the tripeptide level may not significantly alter the
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side chain topography and/or the accessibility of key
functional groups important for interaction with the
receptor.

The discovery that formylmethionine- and formylmethionine-containing peptides were chemoattractants for polymorphonuclear leukocytes (Schiffmann et al., 1975) initiated a
series of studies aimed at identifying their structure-activity
relationships (Showell et al., 1976; Freer et al., 1980). As a
result, the tripeptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (f'-Met-Leu-Phe-OH) emerged as the prototypic
chemotactic tripeptide. It has been demonstrated that the Nformyl-Met at position 1 and the Phe at position 3 are crucial
for optimal activity, whereas alterations to the Leu at position
2 are well tolerated, provided the substituted amino acid
contains a bulky, hydrophobic side chain group (Freer et al.,
1982). Formyl-Met-Leu-Phe-OH is considered a pan-activator of neutrophils (PMNs) as it stimulates a wide range of
PMN functions from chemotaxis and lysosomal enzyme release to superoxide generation (Becker, 1987). These effects
are mediated by specific cell surface receptors (Aswanikumar
et al., 1977; Williams et al., 1977) and a membrane protein
which binds N-formylpeptides has recently been cloned from
HL-60 cells (Boulay et al., 1990).
Based on NMR (Becker et al., 1979) and x-ray diffraction
data (Morffew and Tickle, 1981), a model which suggests an
extended antiparallel ,6-sheet as the receptor-bound conformation of f-Met-Leu-Phe-OH (Freer et al., 1982) has been
proposed. Additional support for this hypothesis has come
from several investigations (Bismara et al., 1985; Valensin et
al., 1986; Toniolo et al., 1989a). However, the flexibility of the
parent peptide has been established (Bakir and Stevens, 1982;
Edmundson and Ely, 1985; Gavuzzo et al., 1989) and recent
molecular modeling suggests that folded conformations of
chemotactic peptides may be energetically favored (Semus et
al., 1988; Feller and Zimmerman, 1989). Furthermore, conformation-activity studies have revealed that the rabbit peritoneal PMN is able to recognize stereochemically constrained,
folded chemotactic peptide analogs (Iqbal et al., 1984; Sukumar et al., 1985). These folded analogs are nearly as potent or
more potent than the parent peptide, depending on the size
of the hydrophobic side chain group at position 2, and the
nature of the C terminus. Additional work has led to the
1
The abbreviations used are: f, formyl; Ac6c, 1-aminocyclohexanecarboxylic acid; (CH 3 ) 4 Si, tetramethylsilane; 2D COSY, two-dimensional correlated spectroscopy; Dpg, dipropylglycine; ED50, molar
concentration of peptide to induce half-maximal enzyme release;
HPLC, high performance liquid chromatography; LDH, lactate dehydrogenase; NOE, nuclear Overhauser enhancement; PMN, polymorphonuclear neutrophilic leukocyte; TEMPO, 2,2,6,6-tetramethylpiperidine-l-oxyl; TFE, trifluoroethanol.
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proposal of a folded type II {J-turn as the receptor bound
conformation (Raj, 1986; Toniolo et al., 1989b). These findings
formed the rationale for our present investigation in which
we describe the biological activity of a stereochemically constrained, extended chemotactic peptide analog as compared
to a folded type II {J-turn analog in an attempt to assess the
role of backbone conformation on secretagogue potency in the
human peripheral blood neutrophil. The activity of the peptides suggests that the chemotactic peptide receptor in human
neutrophils has a definite preference for an extended peptide
ligand. The results also emphasize that the difference in the
backbone conformation of the tripeptides may not significantly alter the topography of the side chains and accessibility
of the functional groups for interaction with the receptor.
EXPERIMENTAL PROCEDURES
Selection of Peptides-N-Formyl-Met-Dpg-Phe-OMe was selected
to generate a stereochemically constrained extended conformation
based on theoretical and crystal structure studies which indicated
that the Dpg residue is able to stabilize the extended backbone
conformation (Benedetti et al., 1984; Bonora et al., 1984; Toniolo and
Benedetti, 1988). N-Formyl-Met-Ac 6c-Phe-0Me was chosen for investigation since it has been found to be more active than the parent
peptide in stimulating lysosomal enzyme release from rabbit peritoneal leukocytes, and its backbone conformational preference for a
type II (:/-turn has been established (Toniolo et al., 1989b). FormylMet-Leu-Phe-OH and its methyl ester derivative were also synthesized and studied because of their high biological activity and their
crystal and solution conformational properties have previously been
established (Bakir and Stevens, 1982; Raj and Balaram, 1985). All
four peptides were used as conformational probes to study the influence of peptide backbone conformation on secretagogue activity.
Peptide Synthesis and Purification-All chemicals and solvents
were of the highest purity available and used without further purification. Tertiarybutyloxycarbonyl-L-methionine was purchased from
Bachem (Torrance, CA). Phe-OMe hydrochloride, 1-hydroxybenzotriazole, and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide were
from Sigma. Ac6c was obtained from Fluka Chemicals (Ronkonkoma,
NY) and thionyl chloride, ethylcyanoacetate, and 1-bromopropane
were from Aldrich Chemical Co. The peptides under study were
synthesized as outlined in Fig. 1 by solution phase procedures using
standard carbodiimide/1-hydroxybenzotriazole-mediated coupling
(Konig and Geiger, 1970). The Dpg-OEt was synthesized as described
by Hardy and Lingham (1983). The peptides were purified and
analyzed on a Rainin Dynamax-60A reversed-phase C, 8 column (10
x 250 mm) coupled to a guard column (10 X 50 mm) employing an
acetonitrile-water or methanol-water (each with 0.1 % trifluoroacetic
acid) linear gradient elution (flow rate: 2.0 ml/min) mode with detection at 230 and 240 nm. The HPLC trace of the purified Dpg analog
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is shown in Fig. 2. The purity of the peptides was also checked on
thin-layer chromatography by three different solvent systems
(CHCls/MeOH (95:5), n-1-butanol/acetic acid/H 2 0 (4:1:1), and
CHCla/EtOH (9:1)) using iodine stain for detection. For biological
assays the purified peptides were stored in glass ampules, sealed
under nitrogen, and kept at -70 °C until the day of the assay.
X-ray Crystallographic Analysis-Single crystals of N-formyl-LMet-Dpg-L-Phe-OMe were grown by slow evaporation from a mixture
of benzene and hexane, C2,H3,N30 5 S · 2/3(C 6H6) fw = 531.6. The
tripeptide crystallizes in an orthorhombic unit cell with dimensions
of a = 12.204 A, b = 20.226 A, c = 23.961 A; space group I222. There
are eight peptide molecules per unit cell of volume 5914.8 A3 • X-ray
diffraction data was collected on an Enraf-Nonius CAD4 diffractometer equippe9" with a graphite monochromator using CuK" radiation (1 = 1.54 A), and all calculations were performed on a VAX
computer using SDP /VAX (Frenz, 1985). The crystal structure was
solved by the application of direct methods using SHELXS-86 (Sheldrick, 1985) and successive weighted Fourier maps. Full-matrix least
squares were used for refinement, with atoms being treated isotropically in the initial stages and with anisotropic parameters in the final
stages of refinement. Hydrogen atoms were not included in the
calculations. The final weighted R factor for 2586 reflections where I
> 2s was 0.085. The structure shown in Fig. 3A was plotted with the
ORTEP computer program (Johnson, 1965). (A list of atomic coordinates and structure factor tables are available upon request.)
Spectroscopic Studies-The 500-MHz 'Hand 125-MHz "1C NMR
spectra were recorded using a Varian VXR-500 NMR spectrometer
equipped with a SUN 3/110 computer. The concentration of peptide
used for the two-dimensional correlated spectroscopy (2D COSY) and
difference nuclear Overhauser enhancement (NOE) studies were 25
and 10 mM in (CD,1),SO and CDCl:i, respectively. Peptide concentration for all other NMR studies was 2 mM. In the NOE studies, the
perturbed and normal spectra were recorded sequentially in different
parts of the memory, each with 16 K data points. The perturbed and
normal spectra were obtained with low-power on-resonance saturation of a peak and by off-resonance shifting of the irradiation frequency, respectively. IR spectra were recorded on a Bio-Rad FTS-40
spectrometer. Solutions of the peptide were prepared in dry CHCh
and spectra recorded using pathlengths from 1 to 5 mm. CD spectra
were recorded on a Jasco J-600 spectropolarimeter interfaced with an
IBM PS/2 microcomputer with measurements carried out at 22 °C
using a 0.1-mm pathlength and 2 mM peptide concentrations.
Neutrophil Isolation-Whole blood was collected by venipuncture
from healthy human volunteers and diluted (6:1) in acid citrate
dextrose anticoagulant. The neutrophils (PMN) were isolated using
Histopaque gradients followed by dextran sedimentation and hypotonic lysis as described by Metcalfe et al., 1986. PMN were washed
twice and resuspended in Dulbecco's phosphate-buffered saline with
0.1 % bovine serum albumin and 0.1 % glucose, pH 7.3. Cell purity was
assessed by Wright-Giemsa stain and was routinely 95-97% PMN.
Enzyme Release Assays-Peptide-induced degranulation (release
of (:i-glucuronidase) was assessed as a measure of biological activity.
Lactate dehydrogenase (LOH) released from the cytoplasm was measured to determine cell viability at the end of each assay. This value
never exceeded 5% of the total LOH. The secretagogue activity of
each peptide was tested at eight different concentrations using a
timed assay. Briefly, PMNs (1 X 107 /ml) in Oulbecco's phosphate-
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FIG. 1. Scheme employed for solution-phase synthesis of Nformylated chemotactic peptides. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/1-hydroxybenzotriazole (HOBt) mediated coupling procedures were employed using methylene chloride
(CH,Cl,) and N,N-dimethyl formamide (DMF) to solubilize Boeamino acids and Boe-protected dipeptides, respectively.

TIME

(min)

FIG. 2. HPLC trace of the purified f-Met-Dpg-Phe-OMe on
a Rainin Dynamax-60A reversed phase C 18 column (10 x 250
mm) using acetonitrile and water as the solvent system (flow
rate: 2 ml/min). The peptide (100 µg) was loaded into an injection
loop of 100-µl capacity and detected at 230 nm. The gradient used is
shown as a dashed line.
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(0.5+x, 0.5-y, 0.5-z)

(·0.S+x, ·O. 5-y, ·O. 5-z)

FIG. 3. A, a perspective view of the molecular conformation of f-Met-Dpg-Phe-OMe showing the atomic
numbering scheme used. Hydrogen atoms are not included in the fig. for clarity. B, the intermolecular association
of the peptide molecules involving the asymmetric unit (x, y, z) as viewed from the crystallographic c axis. The
intermolecular hydrogen bonds (dashed lines) formed between Met NH (Nl) and Dpg CO (02) groups (2 - x, - y,
z) of symmetry related molecules forming antiparallel /3-strands and between Phe NH (N3) and Met CO (01)
groups (-0.5 + x, -0.5 - y, -0.5 - z, and 0.5 + x, 0.5 - y, 0.5 - z) of symmetry-related molecules giving rise to
parallel /3-strands are shown.

buffered saline with cytochalasin B (final assay concentration of 5
µg/ml) were aliquoted (0.75 ml) into 1.75-ml polypropylene tubes
containing 0.6 ml of Dulbecco's phosphate-buffered saline and allowed to equilibrate at 37 °C in a shaking water bath for 5 min. The
peptide stimulus was added (0.15 ml) and the mixture incubated for
20 min before being placed on ice and subsequently centrifuged at
800 X g for 5 min at 4 °C to pellet the cells. PMN supernatants were
then tested in duplicate for the presence of these enzymes as previously described (Metcalfe et al., 1986). Maximum stimulated release
was calculated as a percentage of the total enzyme present. Total /3glucuronidase and LDH was determined by adding 0.3% (v/v) Triton
X-100 and vortexing for 2 min prior to centrifugation. Controls run
for each experiment included spontaneous release (no peptide stimulus) and total release of both enzymes in the presence and absence
of cytochalasin B, and spontaneous release at the highest (CH 3 }eSO
concentration run in the experiment. This value never exceeded 0.5%
(CH,) 2SO. To control for donor variability and to get a relative
measure of their activity all four peptides were tested in each experiment and their potency relative to the parent peptide calculated as
EDr,o f-Met-Leu-Phe-OH/ED 50 test peptide. Pilot studies were run
where total enzyme release was assessed in the presence and absence
of high concentrations of each peptide (10 µM) to insure that the
peptides were not interfering with the detection of enzyme activity.
Additionally, kinetics experiments revealed that the degranulation
response was essentially complete by 5 min; however, we chose a 20min incubation time for convenience since the spontaneous release
of both LDH and /3-glucuronidase did not increase significantly over
this time interval. Dose-response curves were generated from each
experiment using the Sigma-Plot program (Jandel Scientific Corp.,
Corte Madera, CA) and the ED 50 values taken directly from the
graphs. (See Fig. 11 for a composite graph from five experiments
showing the average values of enzyme release for each peptide at
eight different concentrations.) The error bars represent the standard
error of the means. A third order polynomial gave the best fit to these
data with R values above 0.99 for each of the four curves shown.
RESULTS AND DISCUSSION

Molecular Structure
The molecular structure of f-Met-Dpg-Phe-OMe is shown
in Fig. 3A and the relevant torsional angles are provided in
Table I. The peptide molecules assume an extended /3 conformation with a twist both at the N and C termini of the peptide
backbone. The Dpg residue at position 2 has the </> and f
values of 173.1 ° and 179.0°, respectively, and adopts an extended conformation with a short contact between the NH
and CO groups giving rise to a C5 ring structure (N2H- - -02
= 2.074 A; r angle (N2-C2A-C'2) = 105.4 °) (Toniolo, 1980,
1989). Similar C5 structures have been observed for the Dpg

TABLE I
Relevant torsional angles (0) for f-Met-Dpg-Phe-OMe
The torsional angles for rotation about bonds of the peptide backbone(</>,>/;, w) and side chains (x1, x'', x 2 , x 2 ', x 3 ) are described as
in IUPAC-IUB Commission on Biochemical Nomenclature (1970).

Met

w

x'
x"
x'

x2,
x3

-75.8
-30.4
178.9
57.4

Dpg

(6)
(6)
(4)
(6)

178.2 (4)

0

173.1
179.0
173.1
-62.3
53.2
176.8
175.4

Phe

(4)
(4)
(4)
(5)
(5)
(6)
(5)

-96.7
33.6
-178.3
-58. 7

(6)
(6)
(6)b
(7)

106.5 (9)
-65 (1)

-74.6 (7)

Estimated standard deviations are in parentheses.
b With 04C24 of the carboxymethyl group.
0

residue in the crystal structures of homooligopeptides containing dipropylglycines (Benedetti et al., 1984; Toniolo and
Benedetti, 1988). The </> and f values for the Met and Phe
residues (Table I) are much lower than the </> and f values
(-130°, ±135°, respectively) observed for oligopeptides exhibiting ideal extended /3-sheet structures (Karle et al., 1983,
1988). The lower </> and f values of the Met and Phe residues
cause a twist in the extended backbone of the peptide. Twisted
antiparallel /3-sheet structures have been observed in the
crystals of oligopeptides containing L-cystine (Karle et al.,
1989; Raj et al., 1990) and in globular proteins (Chothia, 1973;
Salemme and Weatherford, 1981; Richardson, 1981). Interestingly, the symmetry of the Dpg residue results in the
disposition of a hydrophobic propyl chain adjacent to both
the Met and Phe side chain groups even though the Met and
Phe side chains lie on opposite sides of the peptide backbone.
The hydrogen bonding pattern between the tripeptide molecules is shown in Fig. 3B and the geometry of the hydrogen
bonds is provided in Table II. There are four intermolecular
hydrogen bonds involving the asymmetric unit (x, y, z). Association of the peptide molecules in the crystal is characterized by a network of intermolecular hydrogen bonds formed
between Met NH (Nl) and Dpg CO (02) groups (2 - x, -y,
z) of symmetry related molecules forming antiparallel /3strands and between Phe NH (N3) and Met CO (01) groups
(-0.5 + x, -0.5 - y, -0.5 - z, and 0.5 + x, 0.5 - y, 0.5 - z) of
symmetry related molecules giving rise to parallel /3-strands.
The Nl- - -02 and N3- - -01 distances, 2.854 and 2.915 A,
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TABLE II
Geometry of the hydrogen bonds observed in the f-Met-Dpg-Phe-OMe
crystal structure
D

H

A

D-H

D ... A

H ... A

D-H ... A

Code"

1.944
2.000

159.2
156.0

2

A
Nl
N3

NlH2
N3H24

02
01

0.951
0.972

2.854
2.915

1

0
N

%

A
:i:

"(1) NlH2 (x, y, z) ... 02 (2 -x, -y, z) and NlH2 (2 -x, -y, z) ... 02
(x, y, z); (2) N3H24 (x, y, z) · · -01 (0.5 + x, 0.5 - y, 0.5 - z) and
N3H24 (-0.5 + x, -0.5 - y, -0.5 - z). · -01 (x, y, z).
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FIG. 5. 500 MHz H (A) and 125 MHz C (B) NMR spectra
of f-Met-Dpg-Phe-OMe (2 mM) in (CD 3 ).SO at 25 °C.
FIG. 4. Crystal packing of f-Met-Dpg-Phe-OMe and benzene solvent molecules in the unit cell. Eight peptide molecules
in the orthorhombic unit cell are shown along with the benzene
solvent molecules. Alternating hydrophobic and hydrophilic channels
exist within the lattice along both the crystallographic a and c axes.

respectively, agree well with the average value observed in the
crystals of chemotactic peptide analogs (Eggleston, 1988,
1990; Gavuzzo et al., 1989). It is quite unusual to observe that
the Dpg CO group which shows a short intramolecular
NH- - -0 contact with the Dpg NH group, is also involved in
intermolecular association. The much lower </J and -./; angles
observed for Met (-75.8°, -30.4°) and Phe (-96.7°, 33.6°)
residues in the crystal structure may presumably be due to
the involvement of the NH groups of these residues in strong
intermolecular hydrogen bonding within the lattice structure.
The twist observed in the peptide backbone can be attributed
to these intermolecular hydrogen bonds as well as other
hydrophobic/hydrophilic crystal packing forces.

Crystal Packing
The crystal packing of peptide and benzene solvent molecules in the unit cell is shown in Fig. 4. Alternating hydrophilic
and hydrophobic channels exist within the lattice along both
the crystallographic a and c axes. At the edges and at the
center of the unit cell, there is a clustering of aromatic rings
from the Phe side chains and the benzene molecules along
the a axis, which results in the formation of aromatic channels
passing through the lattice in this direction. In contrast,
hydrophilic channels exist above and below the central aromatic channel along the a and c axes where parallel and
antiparallel hydrogen bonds are formed between adjacent
peptide molecules.

NMR Studies in Solution
Assignment of Resonances-The 500 MHz 'H- and 125MHz 1 '1C NMR spectra of the Dpg analog shown in Fig. 5 are
fully consistent with its primary structure. The singlet resonance that occurs at 8.1-8.2 ppm both in CDC13 and (CDJ 280
was recognized as the formyl proton by its characteristic
chemical shift while the Dpg NH resonance was unambigu-

ously recognized as the other singlet resonance at 7.38 ppm
in (CD:1) 280. In CDCb, it was buried under the aromatic
resonances, and it was assigned by solvent titration experiment (Fig. 6A). The Met and Phe doublet resonances in these
solvents were assigned by spin decoupling experiments. In
(CD3)z80, the spin system connectivities of NH, C"H, C#H2,
C 1 H 2 , and C'H:1 resonances were also established from the
2D COSY spectrum (Fig. 7).
Delineation of Hydrogen-bonded NH Groups-The involvement of NH groups in intramolecular hydrogen bonding was
probed using solvent and temperature-induced NH chemical
shifts, paramagnetic radical-induced line broadening, and hydrogen-deuterium exchange effects on NH resonances (Kopple and Schamper, 1972; Ohnishi and Urry, 1972; Pitner and
Urry, 1972; Wuthrich, 1976; Kessler, 1982). The results are
summarized in Fig. 6 and 'H NMR parameters are provided
in Table III. A peptide concentration of -2 mM was used to
avoid the influence of peptide aggregation on the 'H NMR
parameters (Raj and Balaram, 1985). In the solvent titration
experiment (Fig. 6A), the Met and Phe NH resonances show
substantial downfield shifts (2.1 and 2.2 ppm, respectively)
with increasing concentrations of (CD3)z80, while the Dpg
NH resonance shows only a slight downfield shift of 0.3 ppm
(Table III). In (CD3)z80, the temperature coefficient (do/dT)
of the Dpg NH is quite low (0.0009 ppm/K) indicating solventshielding of this NH group, whereas the Met and Phe NH
groups show relatively high do/dT values of 0.0048 and 0.0054
ppm/K, respectively, suggestive of NH groups which are freely
accessible to the solvent (Fig. 68). Likewise, addition of the
paramagnetic radical probe 2,2,6,6-tetramethylpiperidine-loxyl (TEMPO) to the peptide in CDCb solution results in a
dramatic broadening of the Met and Phe NH resonances,
whereas the Dpg NH resonance is much less affected (Fig.
6C). Furthermore, the rate of deuterium-hydrogen exchange
in (CD3)z80 is substantially faster for the Met and Phe NH
resonances than for the Dpg NH resonance (Fig. 6D). These
findings suggest that both the Met and Phe NH groups are
freely accessible to the solvent and not involved in hydrogen
bonding while the Dpg NH is inaccessible to the solvent and
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FIG. 6. Delineation of hydrogenbonded NH groups in f-Met-DpgPhe-OMe. A, solvent dependence of NH
chemical shifts in CDCb-(CD"hSO mixtures as a function of solvent concentration. B, temperature dependence of NH
chemical shifts in (CD 3 ) 2 SO. The ternperature coefficients, do/dT (ppm/K) of
the NH resonances are shown in the
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TEMPO radical in CDCb containing
0.6% (CD:ihSO. TEMPO concentration
is indicated on the traces. D, the effect
of hydrogen-deuterium exchange on NH
resonances in (CD 3 ) 2SO. Time intervals
after the addition of 3% D 20 (v/v) are
indicated on the traces. A peptide concentration of 2 mM was used in all experiments.
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is presumably hydrogen bonded both in (CD 3)zS0 and CDCb.
This shielding is consistent with the crystal structure analysis
which has established the intramolecular short contact between the Dpg NH and the Dpg CO groups as part of a C5
ring structure. The JNH-C"H values (7.6-8.1 Hz) observed for
Met and Phe residues in CDCls and (CD3) 2SO shown in Table
III suggest values for </> of --90° and --150° (Karplus 1963;
Pardi et al., 1984). Both these values and the absence of
intramolecular hydrogen bonding of the Met and Phe NH
resonances provide evidence in favor of an extended peptide
backbone structure in (CD3)2SO and CDCls. In addition, the
</> value (-90°) for the Phe residue deduced from NMR data
is in close agreement with the value obtained from the crystal
structure. Furthermore, the unusual chemical shift difference
between the Dpg C 11 HA and Cl'HB in CDCls and (CD3)zSO (-1
ppm) as well as c~HA and c~HB resonances in (CD3)2SO (Fig.
5A) suggests a ring current effect from the adjacent Phe side
chain (Bovey et al., 1988). This is also consistent with the
crystal structure (Fig. 3A) where the Phe side chain is in a
position to exert a substantial shielding effect on these protons. Taken together, these data indicate that the Dpg analog
has a preference for an extended (3 structure in solvents of
widely varying polarities and hydrogen bonding capabilities
and the solution conformation is in good agreement with the
crystal structure.

NOE Studies
NOE studies were carried out to provide additional information on the backbone conformation (Rao et al., 1983).
Extended antiparallel (3 structures can be recognized by the

7.0

6.4

(ppm)

8.5

T.60MIN

L

T • SMIN

J_

T = OMIN

1

8.0

7.5

observation of NOEs between the CtH and N;+1H, since the
distance between these nuclei is <3 A (Kuo and Gibbons,
1980; Billeter et al., 1982). The results are summarized in
Table IV. Fig. 8 shows a representative one-dimensional difference NOE spectra in CDC13 where the Phe NH has been
irradiated and an intensity enhancement of 3.6% for Dpg
C~HB and 3.0% for the cwHB is observed. Irradiation of the
Dpg NH resonance gives rise to 4.1 % ((CD 3)zS0) and 7.8%
(CDCls) of NOEs on the Met C"H resonance. In the reverse
experiment, the irradiation of the Met C"H gives rise to NOEs
on the Dpg NH (Table IV). NOEs are also observed between
the formyl proton and the Met NH both in CDCls and
(CD3)2SO, suggesting that the formyl H and Met NH are in
cis geometry as observed in the crystal structure (Fig. 3A).
The observed interresidue NOEs are consistent with an extended antiparallel (3 conformation where NOE connectivities
are expected between the formyl H and Met NH, between the
Met C"H and Dpg NH, and between Phe NH and Dpg C~H,
c~·H (Kuo and Gibbons, 1980; Billeter et al., 1982), A graphic
representation of the through-space connectivities and the
proposed antiparallel (3 conformation shown in Fig. 8 are
consistent with the NOE data in CDCls and (CD3)2SO solutions.

Fourier Transform Infrared Studies
The NH and CO stretching regions in the IR spectra of the
Dpg analog in CHCls solutions are shown in Fig. 9. Even at
low concentrations (3 x 10-4 M) the peptide shows a weak
band at 3359/cm (Fig. 9A) which is characteristic of a hydrogen bonded NH in addition to the free NH band at 3427/cm
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TABLE III
NH group" NMR parameters for f-Met-Dpg-Phe-OMe

Met-NH' Dpg-NH

Parametersb

t.o(ppm) = o[(CD 3 ),SO] - o(CDCla)
do/dT(ppm/K) (CD 3 )2SO
JNH-C°'H (Hz) CDCb
JNH-C°'H (Hz) (CDa),80

2.1
0.0048
7.8
7.6

0.3
0.0009

Phe-NH

2.2
0.0054
7.8
8.1

" Peptide concentration = -2 mM.
h Assignments made as described in the text.
TABLE IV
One-dimensional difference NOE data" for f-Met-Dpg-Phe-OMe

Irradiated

NOE

Observed

(CD 3 ) 2 SO

CDC'3
%

Formyl H
Met NH
MetC"H
DpgNH
PheNH

Met NH
Formyl H
DpgNH
Met C"H
DpgC~HB
DpgC~'HB

4.0
3.7
4.1 b
7.81
3.6
3.0

0.1
8.7
1.5
4.1
2.2
1.6

"Only interresidue NOEs are tabulated.
b The percentage NOEs between the Met C"H and Dpg NH have
been assessed in CDCb with 0.6% (CD 3 ),SO, as the NH resonance in
the off-resonance spectrum in CDCb is buried under the aromatic
resonances.

(Bonora et al., 1984). The band observed at 3359/cm even at
low concentrations suggests the presence of a weak intramolecular hydrogen bond in the peptide molecule (Bardi et al.,
1985; Raj et al., 1988), which is consistent with both the

crystal structure and the NMR data. In the carbonyl-stretching region (Fig. 9B) the weak band observed at 1692/cm
provides further support for an extended structure (Miyazawa,
1967). However, an exciton split of only 29/cm is observed at
high concentrations suggesting that ~-sheet structures formed
by aggregation of the peptide molecules are not fully antiparallel. The exciton split is increased to 45/cm at low concentration presumably due to the formation of a more orderly
extended conformation of the peptide backbone (Krimm and
Bandekar, 1986).
CD Studies
Circular dichroism studies were carried out on both the Dpg
peptide and the Ac6c peptide in methanol (MeOH), trifluoroethanol (TFE), and trimethyl phosphate (TMP) in an attempt to assess the solvent dependent conformational change
of the peptide backbone. The CD spectra of the Dpg and Ac 6c
analogs recorded between 175 and 250 nm in these solvents
are shown in Fig. 10, and the CD parameters are summarized
in Table V. Though CD is a sensitive technique for the
prediction of secondary structure of polypeptides (Beychok,
1967), the limitations on the use of CD for conformational
analysis of small linear peptides with aromatic residues, such
as those studied here, have been reported (Toniolo and Bonora, 1976; Toniolo et al., 1989a). However, CD studies do
provide useful information on the relative conformational
flexibility of these two constrained peptides. The Dpg peptide
exhibits a weak positive CD band at -215-220 nm (Fig. lOA)
and an intense negative band at -190-195 nm in MeOH and
TMP. In TFE, it exhibits a positive shoulder at -213 nm, a
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TABLE

V

CDa parameters for chemotactic peptide analogs
6, 3

f-Met-Dpg-Phe-OMe
A (nm)

2,1 x lo-3M

I

6.3 x 10-J H

12,6

MeOH

TMP

TFE

219
+ 13051
192
-32193

220
+8551
189
-52353

213
+6121
193
+10048
183
-36248

209
+9041
196
+18151
186
-14047

220
+17524
196
+44257
186
-53845

212
+18892
194
+47948
184
-51031

x 10-4 K

X

[/i]M
A (nm)
[/i]M

}Q-J }t

A (nm)
[/i]M

3SOO

:uoo

3$00

noo

I 900

17~0

17~

l6~

f-Met-Ac 6c-Phe-0Me
A (nm)

I~

WAV!NUHBER (cm-1)

[/i]M

FIG. 9. Partial IR spectra of f-Met-Dpg-Phe-OMe in dry
CHCla at various concentrations indicated against the traces.
A, NH stretching region showing free NH bands at 3420/cm and
hydrogen-bonded NH band at 3359/cm. B, CO stretching region
showing the strong bands at 1745 and -1663/cm and a weak band at
1692/cm. Note the shift in the strong band from 1663 to 1647/cm as
the peptide concentration is decreased to 3 X 10-• M.

A

B

190

205

220

235

'"

WAVELENGTH (nm)

FIG. 10. CD spectra of stereochemically constrained formylpeptides. f-Met-Dpg-Phe-OMe (A) and f-Met-Ac 6c-Phe-0Me
(B) in TFE, trimethyl phosphate (TMP), and methanol (MeOH) at
2 mM peptide concentration.

positive maximum at -193 nm, and a strong negative minimum at -183 nm. The reported CD spectrum of the parent
chemotactic peptide, f-Met-Leu-Phe-OH which has been established to adopt an extended {3 conformation in the solid
state by x-ray diffraction and in solution by NMR is quite

A (nm)
[/i]M
A (nm)
[/i]M
a
b

Peptide concentration: -2 mM.
[/i]M is molar ellipticity expressed as deg cm 2 dmol- 1.

similar in TFE (Bakir and Stevens, 1982). The folded Ac6c
analog shows two weak shallow positive bands between 194
and 220 nm in all three solvents with a maximum at -196
and a strong negative band at -186 nm. Similar CD spectra
observed for the pentapeptide Tyr-Pro-Gly-Asp-Val in water
(Dyson et al., 1988) and for pivaloyl-L-prolyl-a-aminoisobutyryl-N-methylamide in MeOH (Crisma et al., 1984) have
been interpreted in terms of a {3-turn conformation, which is
consistent with the previously established {3-turn structure of
f-Met-Ac6c-Phe-0Me (Toniolo et al., 1989b). Even though it
is not safe to relate CD spectra of linear oligopeptides in terms
of any specific conformation, it appears from CD studies that
the stereochemically constrained, extended Dpg peptide
shows some conformational flexibility, whereas the folded
Ac 6c analog appears quite rigid.

Biological Activity Studies
The peptides were examined for their ability to induce the
release of {3-glucuronidase from cytochalasin B-treated human
peripheral blood neutrophils. The dose-response curves for /3glucuronidase release and ED5o values (the molar concentra-
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FIG. 11. Dose-response curves generated using the Sigma-

Plot program (Jandel Scientific Corp., Corte Madera, CA) for
formylpeptide-induced .B-glucuronidase release from human
neutrophils. ED 50 values taken from the curves and the potency
ratio (ED.so of f-Met-Leu-Phe-OH/EDso of test peptide) are also
shown. The error bars represent the standard error of the means
calculated from the percentage release values of five separate experiments. A third order polynomial gave the best fit to these data with
R values above 0.99 for each of the four curves shown.

tion of the peptide which would induce half-maximal enzyme
release) are provided in Fig. 11. The maximum formylpeptideinduced release of /J-glucuronidase ranged from 40 to 45% of
the total amount of enzyme detectable with f-Met-Dpg-PheOMe consistently showing 3-5% higher maximum release
values than the other three peptides tested. In addition to its
slightly higher efficacy, f-Met-Dpg- Phe-OMe was consistently
the most potent secretagogue for the human PMN, being -8and 16-fold more active than the parent peptide and the
folded Ac6c analog, respectively. We also found f-Met-Ac6cPhe-0Me and f-Met-Leu-Phe-OMe to be consistently less
active (-0.5 X) than the parent peptide (f-Met-Leu-Phe-OH).
It is worth mentioning that these same two peptides have
been shown to be -5 x more active than the parent peptide,
when tested on rabbit peritoneal neutrophils (Sukumar et al.,
1985; Toniolo et al., 1989b). The ED 50 observed for f-MetLeu-Phe-OMe (Fig. 11) is in good agreement with a previously
published report (Belleau et al., 1989). It is noteworthy that
for these tripeptides the simple conversion of the C-terminal
functional group from a carboxylic acid to the methyl ester
results in a loss of secretagogue activity in human peripheral
blood neutrophils. The finding that f-Met-Ac6c-Phe-0Me is
equipotent to f-Met-Leu-Phe-OMe suggests that the replacement of the Leu side chain at position 2 by a cyclohexane
ring does not substantially alter peptide activity.
Conformation and Biological Activity
Despite the methyl ester function at the carboxyl terminus,
f-Met-Dpg-Phe-OMe is -8 x more potent than the parent
peptide and 16 x more potent than f-Met-Ac 6c-Phe-0Me.
The enhanced activity of the extended Dpg analog and the
decreased activity of the folded Ac 6c analog relative to the
parent peptide suggest that the extended backbone may be
the preferred ligand conformation for the human neutrophil
chemotactic peptide receptor. This is consistent with Freer's
original proposal that the receptor-bound conformation offMet-Leu-Phe-OH is an extended /J-structure (Freer et al.,
1982). However, our findings do not rule out the possibility
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that other factors are responsible for these alterations in
biological activity.
In addition to peptide backbone conformation, the topography of the side chain groups will also influence activity.
The side chain orientation may in part account for the increased potency of the Dpg analog. One can speculate that
the inherent symmetry of bilateral propyl side chains of Dpg
essentially increases the total number of side chains in the
tripeptide from three in the parent peptide to four in the Dpg
analog (Fig. 1A). This may increase the probability of having
three side chain groups of the peptide aligned in a favorable
orientation for binding to the receptor. In this regard it should
be noted that when f-Met-Leu-Phe-OH was cocrystallized
with a protein receptor the preferred orientation of the Met,
Leu, and Phe side chains showed the three hydrophobic
groups on one face of the peptide backbone swept back into a
hydrophobic pocket (Edmundson and Ely, 1985). Since side
chain group topography and peptide backbone conformation
are intimately associated (Lyu et al., 1990) one must also
consider that these two factors together may affect the surface
accessibility of some as of yet unidentified critical backbone
functional group in the initial binding interaction between
the peptide and receptor. This latter possibility may be very
important if an induced fit mechanism is at work. Moreover,
it may be possible for peptides with different backbone conformations to display similar side chain orientations (Hruby
et al., 1990). Other possibilities which cannot be ruled out on
the basis of this work include susceptibility of the different
peptides to enzyme degradation or the presence of more than
one receptor on the human PMN.
In summary, we have synthesized a unique chemotactic
peptide analog f-Met-Dpg-Phe-OMe and shown that the peptide prefers an extended backbone conformation both in solution and in the solid state with a C5 conformation at
position 2. We have assessed the biological activity of this
peptide in human neutrophils and found it to be a more potent
secretagogue than the stereochemically constrained type II /Jturn folded chemotactic peptide analog (f-Met-Ac 6c-Phe0Me) and the unconstrained parent peptides (f-Met-LeuPhe-OMe and f-Met-Leu-Phe-OH). While these findings are
consistent with the hypothesis that a formylpeptide receptor
prefers a ligand with an extended peptide backbone (Freer et
al., 1982), the biological activity of all four peptides (EDso
-10- 8-10- 9 M) provides indirect evidence in support of the
induced fit mechanism originally proposed by Edmundson
and Ely (1985). It should also be noted that the importance
of side chain topography is as yet undefined for the formylpeptides. This may be important particularly at the tripeptide
level where the orientation of the side chains in either a folded
or extended tripeptide may be similar enough to activate the
receptor. Finally, we have observed that in the human PMN
model system f-Met-Leu-Phe-OMe and f-Met-Acsc-Phe-OMe
are less active than f-Met-Leu-Phe-OH. This is in contrast
to the findings in the rabbit peritoneal neutrophil model
(Sukumar et al., 1985; Toniolo et al., 1989b) where the methyl
ester derivatives are reported to be more potent than the
parent peptide.
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